430 related articles for article (PubMed ID: 7498617)
21. [Non-fermenting Gram-negative bacilli: distribution in clinical specimens and antimicrobial susceptibility].
Merino LA; Ronconi MC; Marín M; Hreñuk GE; Pato AM
Rev Latinoam Microbiol; 1999; 41(4):279-84. PubMed ID: 10932769
[TBL] [Abstract][Full Text] [Related]
22. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243
[TBL] [Abstract][Full Text] [Related]
23. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
Bastianini L; Sposini T; Bartoli A; Marconi P
Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
Bujdáková H; Kallová J; Lausová A; Kettner M
Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
[TBL] [Abstract][Full Text] [Related]
26. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
Korten V; Ulusoy S; Zarakolu P; Mete B;
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):453-7. PubMed ID: 17888609
[TBL] [Abstract][Full Text] [Related]
28. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
29. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance. Nosocomial gram-negative infection.
Gransden WR
J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
[No Abstract] [Full Text] [Related]
31. Comparative analysis of antibiotic resistance characteristics of Gram-negative bacteria isolated from laying hens and eggs in conventional and organic keeping systems in Bavaria, Germany.
Schwaiger K; Schmied EM; Bauer J
Zoonoses Public Health; 2008 Sep; 55(7):331-41. PubMed ID: 18667026
[TBL] [Abstract][Full Text] [Related]
32. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
[TBL] [Abstract][Full Text] [Related]
33. [Nonfermentative gram-negative bacteria: isolation rates and antibiotic sensitivity].
Bogomolova NS; Bol'shakov LV; Kuznetsova SM; Oreshkina TD
Anesteziol Reanimatol; 2010; (3):12-8. PubMed ID: 20734840
[TBL] [Abstract][Full Text] [Related]
34. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
Patzer JA; Dzierzanowska D; Turner PJ
J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
[TBL] [Abstract][Full Text] [Related]
35. [Antibacterial drug resistance of gram-negative agents causing urinary infections in female outpatients in Russia: results of multicenter study].
Strachunskiĭ LS; Sekhin SV; Abramova ER; Reshed'ko GK; Petrochenkova NA; Eĭdel'shteĭn IA; Suvorov MM; Krechikova OI; Il'ina VN; Petrova TA; Gugutsidze EN; Furletova NM
Ter Arkh; 2000; 72(6):30-5. PubMed ID: 10900645
[TBL] [Abstract][Full Text] [Related]
36. [Antibiotic sensitivity of gram negative bacilli isolated from urinary tract infections at NUHC of Cotonou (Benin) from March to December 1992].
Anagonou SY; Eslahpazire J; Makoutodé M; Josse R; Massougbodji A; Sadeler BC
Bull Soc Pathol Exot; 1994; 87(4):223-5. PubMed ID: 7866038
[TBL] [Abstract][Full Text] [Related]
37. [The antibiotic sensitivity of microorganisms isolated from newborn infants].
Avdieieva LV
Mikrobiol Z; 2000; 62(3):43-8. PubMed ID: 10932542
[TBL] [Abstract][Full Text] [Related]
38. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
39. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.
Wang H; Chen M;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):201-8. PubMed ID: 15766607
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection.
Webb G; Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Int J Clin Pharmacol Res; 1987; 7(3):203-5. PubMed ID: 3298085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
